Investor Presentation Q1 2023 slide image

Investor Presentation Q1 2023

110 Investor presentation First three months of 2023 GLP-1 market share and market growth in EMEA 80% 60% 40% 20% GLP-1 market growth and Novo Nordisk market share 0% Feb 2020 DKK GLP-1 market size and growth billion 80% -38% 3 67% 5 61% 60% 19 43% 38% 40% 20% 59% EMEA 27 ~43% 61% 0% Feb 2023 Feb 2022 Feb Novo Nordisk Eli Lilly Others 2023 NN market share Market growth (right axis) -NN share of growth Novo Nordisk Competitors -NN growth (right axis) Source: IQVIA, Feb 2023, Value, MAT, EMEA: Europe, Middle East and Africa; NN: Novo Nordisk
View entire presentation